🎙️ If you're interested in learning more about the future of medicine, we invite you to listen to Bcombinator's podcast in which our CEO & Co-Founder, Ángel Alberich-Bayarri, dives into a powerful conversation about how artificial intelligence is the engine of today's healthcare transformation.
📣 Ready for an insightful session on AI and prostate cancer? Join our upcoming webinar: 𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐂𝐚𝐬𝐞 𝐒𝐞𝐬𝐬𝐢𝐨𝐧: 𝐀𝐈 𝐢𝐧 𝐩𝐫𝐨𝐬𝐭𝐚𝐭𝐞 𝐜𝐚𝐧𝐜𝐞𝐫 - 𝐕𝐨𝐥.2 | 𝐖𝐞𝐛𝐢𝐧𝐚𝐫 𝐞𝐧𝐝𝐨𝐫𝐬𝐞𝐝 𝐛𝐲 𝐒𝐄𝐑𝐀𝐌 📅 June 26 🕡 19:00 (CEST – Spain) | 14:00 (GMT-3 – LATAM) 🌐 Language: Spanish This session, endorsed by SERAM - Sociedad Española de Radiología Médica, will feature two renowned radiologists: Dr. Milagros Otero-García (Spain) and Dr. Fernando Losada (Argentina), who will present and discuss real clinical cases. Don’t miss this opportunity to learn from experts in radiology and AI. 📌 Register here: https://bit.ly/4jZSIsk #Radiology #ProstateCancer #HealthcareInnovation #AI #MedicalImagin #QPProstate #webinar
Air pollution is an invisible killer. But its impact? Deeply visible. 🌬️ 4.2M premature deaths/year are caused by air pollution 🌫️ 29% of lung cancer cases are linked to polluted air 📉 Only 30% of lung cancers are detected at early stages Early detection and public action can save lives. ▪️ Promote early screenings — early diagnosis can boost survival rates by up to 80% ▪️ Screen high-risk groups, even in the absence of symptoms Let’s raise awareness and push for action. #LungCancer #HealthAwareness #PublicHealth #EarlyDiagnosis #AI
Quibim is at Jornada Paulista de Radiologia 2025—the largest diagnostic imaging congress in Latin America—taking place May 1-4 in São Paulo. This 55th edition, organized in partnership with the Argentine Society of Radiology (SAR) and the Federación Argentina de Radiología - FAARDIT, brings together the latest innovations, technologies, and trends in radiology. 📍 Visit us at area 121 alongside our Brazilian distributor, AI Precision. We look forward to seeing you there! Sociedade Paulista de Radiologia #JPR2025 #Radiology #Quibim #ArtificialIntelligence #MedicalImaging
💫 April marked a turning point for Quibim! With the announcement of our newly appointed Board of Directors, we have entered a decisive phase of strategic growth and global expansion. In parallel, we continue to advance scientific knowledge through newly published blog articles, clinical case studies, and active participation in leading international forums on innovation and research. Stay connected through our newsletter—more exciting developments are on the horizon👇
That’s a wrap for #AUA2025! From insightful demos to engaging conversations with leading experts, we’re thrilled with the impact QP-Prostate® CAD is making. Missed a chance to connect with Nathan Clark, Joshua Moss, Jason Santos, David Bazaga, or Ángel Alberich-Bayarri Bayarri about our AI-powered prostate cancer solution? Explore QP-Prostate® CAD 👉 https://bit.ly/44fUEIL 📅 Book a demo: https://bit.ly/3GaahY5 #AIinHealth #Urology #CancerScreening #MedicalInnovation
Heading to American Urological Association 2025? Let’s talk about prostate cancer and AI. Get to know QP-Prostate® CAD, our newly FDA-cleared tool available across the U.S. that streamlines fusion biopsies and focal therapy procedures through the power of AI to help uncover aggressive prostate cancer cases that may otherwise go undetected. 📍 Meet us at booth 2455 in Las Vegas 📅 Book a demo: https://bit.ly/3GaahY5 #AUA2025 #Urology #ProstateCancer #AIinHealth #MedicalInnovation
Medical imaging has come a long way, but traditional visual interpretation captures only a fraction of the available information. Enter radiomics - a valuable technology that extracts quantitative data from medical images to improve diagnosis, treatment planning, and research. Scroll right to see how it works and what role QP-Insights plays in all this. To understand it in more detail, explore the whole infographic on our website: https://bit.ly/3OrTBwX #Radiomics #MedicalImaging #PersonalizedMedicine #AIInHealthcare #HealthTech
#WorldLiverDay is the perfect occasion to highlight advances in liver health and how they contribute to a better future. Today we share a study involving our team: the MR-MASH score, a noninvasive tool that accurately identifies metabolic dysfunction-associated steatohepatitis (MASH) in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) using MRI and waist circumference. ✅ Validated in 317 patients across Europe and the U.S. ✅ High diagnostic accuracy (AUC 0.88 discovery / 0.86 validation) ✅ Outperformed the FAST score (p < 0.001) ✅ Enables a two-step screening strategy with >80% PPV QP-Liver-derived imaging biomarkers facilitate automatic calculation of the MR-MASH score. This could transform how we diagnose and treat liver disease—faster, safer, and on a larger scale. https://bit.ly/42owKrO #LiverHealth #MedicalImaging #ClinicalResearch
🗞️ Make sure to read this article from Campus Sanofi, a Spanish-speaking educational platform for healthcare professionals, where they feature Quibim to explain from the inside how it is now possible for clinicians to diagnose earlier, monitor in real time and personalize treatments with the power of AI. ”𝘈𝘐 𝘰𝘷𝘦𝘳𝘤𝘰𝘮𝘦𝘴 𝘵𝘩𝘦 𝘭𝘪𝘮𝘪𝘵𝘢𝘵𝘪𝘰𝘯𝘴 𝘰𝘧 𝘵𝘳𝘢𝘥𝘪𝘵𝘪𝘰𝘯𝘢𝘭 𝘳𝘢𝘥𝘪𝘰𝘮𝘪𝘤𝘴, 𝘰𝘧𝘧𝘦𝘳𝘪𝘯𝘨 𝘮𝘰𝘳𝘦 𝘢𝘤𝘤𝘶𝘳𝘢𝘵𝘦 𝘱𝘳𝘰𝘨𝘯𝘰𝘴𝘦𝘴 𝘢𝘯𝘥 𝘪𝘮𝘱𝘳𝘰𝘷𝘪𝘯𝘨 𝘵𝘩𝘦𝘳𝘢𝘱𝘦𝘶𝘵𝘪𝘤 𝘦𝘧𝘧𝘪𝘤𝘢𝘤𝘺 𝘪𝘯 𝘰𝘯𝘤𝘰𝘭𝘰𝘨𝘺".
